Aldo-Keto Reductase Family 1 Member C1 (AKR1C1) Antibody (Biotin)

Este producto es parte de AKR1C- Aldo-keto reductase family 1 member C
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Aldo-Keto Reductase Family 1 Member C1 (AKR1C1) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx334643
tested applications
ELISA

Description

AKR1C1 Antibody (Biotin) is a Rabbit Polyclonal against AKR1C1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Aldo-Keto Reductase Family 1 Member C1 (AKR1C1)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q04828
Gene ID
1645
Alias
AKR1C1,DDH,DDH1
Background
Antibody anti-AKR1C1
Status
RUO

Descripción

AKR1C1, also known as 20α-hydroxysteroid dehydrogenase, is an enzyme involved in the metabolism of steroid hormones, specifically converting progesterone to its inactive metabolite, 20α-dihydroprogesterone. It plays a critical role in maintaining hormone balance and modulating progesterone-dependent signaling pathways, particularly in reproductive tissues. AKR1C1 also participates in the metabolism of androgens, estrogens, and other steroid hormones, influencing cell proliferation and differentiation. Overexpression of AKR1C1 has been implicated in hormone-driven cancers, such as breast, ovarian, and prostate cancers, where it reduces active steroid hormone levels to promote tumor progression. AKR1C1 also metabolizes reactive aldehydes, such as 4-hydroxynonenal (4-HNE), protecting cells from oxidative stress and chemotherapeutic agents. Its involvement in drug resistance highlights AKR1C1 as a potential therapeutic target in cancer treatment. Additionally, AKR1C1 is linked to neurological functions, as it regulates neurosteroids that modulate synaptic transmission and neuroprotection.

Related Products

EH1577

Human AKR1C1 (Aldo-keto reductase family 1 member C1) ELISA Kit

Ver Producto
FNab10393

AKR1C1 antibody

Ver Producto
P5650

Recombinant Human AKR1C1

Ver Producto